Infectious Diseases News and Research

RSS

PaxVax announces FDA acceptance of IND for PXVX-0200 cholera vaccine

PaxVax Corporation, developer of innovative and socially responsible oral vaccines against infectious diseases, announced that the U.S. Food and Drug Administration (FDA) has accepted its investigational new drug (IND) application for its single-dose oral cholera vaccine, clearing the way to begin clinical trials. The company intends to begin Phase 3 trials later this year.

19 Mar 2012

Pfizer supports First World Congress on Healthy and Active Ageing

As an official partner of the First World Congress on Healthy Ageing, Pfizer reaffirms the company's commitment to promote healthy and active ageing at all stages of life as a basis for enhanced productivity in the Asia Pacific. Pfizer will lead a luncheon symposium today focused on the relationship between health and economic sustainability and the resulting challenges and opportunities of shifting demographics across the region.

19 Mar 2012

Deletion of Hms1 protein inhibits Candida albicans infection

Scientists at the University of Toronto have found a molecular mechanism that plays a key role in the transition of Candida albicans yeast into disease-causing fungus-one of the leading causes of hospital-acquired infection.

17 Mar 2012

Collaborative research discovers genetic marker that identifies pigs with reduced susceptibility to PRRS

A collaborative discovery involving Kansas State University researchers may improve animal health and save the U.S. pork industry millions of dollars each year.

16 Mar 2012

Warming climate may increase risk from Chagas disease

In the spring of 1835, Charles Darwin was bitten in Argentina by a "great wingless black bug," he wrote in his diary. "It is most disgusting to feel soft wingless insects, about an inch long, crawling over one's body," Darwin wrote, "before sucking they are quite thin, but afterwards round & bloated with blood."

16 Mar 2012

Serious climate change-related health problems will affect the world's population

Worldwide increases in the incidences of asthma, allergies, infectious and cardiovascular diseases will result from a variety of impacts of global climate change, including rising temperatures, worsening ozone levels in urban areas, the spread of desertification, and expansions of the ranges of communicable diseases as the planet heats up, the professional organization representing respiratory and airway physicians stated in a new position paper released today.

16 Mar 2012

Third International Symposium on Thymosins in Health and Disease to take place on GW campus

The George Washington University is host to the world's leaders in the area of research that focuses on Thymosins- small proteins present in many animal tissues that have diverse biological activities- Two in particular, thymosins α1 and β4, have potentially important uses in medicine, and research has already progressed from the laboratory to the clinic.

16 Mar 2012

Food borne ailments from imported products on the rise: CDC report

Food-borne illnesses caused by fish, spices, produce and other edibles imported from other countries seems to be on the rise – but the countries of origin may be varied, according to a new report from the Centers for Disease Control and Prevention. The CDC defines a food borne disease outbreak as two or more similar illnesses resulting from the same type of food.

15 Mar 2012

Imported food leading to more foodborne disease outbreaks

Foodborne disease outbreaks caused by imported food appeared to rise in 2009 and 2010, and nearly half of the outbreaks implicated foods imported from areas which previously had not been associated with outbreaks, according to research from the Centers for Disease Control and Prevention, presented today at the International Conference on Emerging Infectious Diseases in Atlanta.

15 Mar 2012

Linking HCV infected people with care is key to reducing related mortality and morbidity

Broader screening to identify people infected with hepatitis C virus (HCV) would likely be cost effective, according to a new report published in Clinical Infectious Diseases.

15 Mar 2012

GenVec 2011 net loss decreases to $7.4 million

Today GenVec, Inc. announced financial results for the fourth quarter and year ended December 31, 2011. For the year ended December 31, 2011, the Company reported a net loss of $7.4 million, or $0.58 per share, compared with a net loss of $12.3 million, or $0.97 per share, for the year ended December 31, 2010.

15 Mar 2012

Scientists discover direct biomarker of Chikungunya fever

Recent breakthroughs in Chikungunya research spearheaded by scientists at A*STAR's Singapore Immunology Network (SIgN) have made great strides in the battle against the infectious disease.

15 Mar 2012

H. pylori bacteria associated with elevated levels of HbA1c

A new study by researchers at NYU Langone Medical Center reveals that the presence of Helicobacter pylori (H. pylori) bacteria is associated with elevated levels of glycosylated hemoglobin (HbA1c), an important biomarker for blood glucose levels and diabetes.

15 Mar 2012

People with higher socio-economic status in developing countries more likely to be obese

Developing nations experiencing economic and social growth might also see growing waistlines among their poorest citizens, according to a new study from Rice University and the University of Colorado.

15 Mar 2012

UMDNJ to receive TB biomarkers grant from Gates Foundation

The University of Medicine and Dentistry of New Jersey (UMDNJ) announced today that Dr. David Alland, professor of medicine, chief of infectious diseases, and director of the Center for Emerging and Re-Emerging Pathogens at UMDNJ-New Jersey Medical School, will receive a tuberculosis (TB) biomarkers grant awarded by the Bill & Melinda Gates Foundation's Grand Challenges in Global Health program, an initiative which seeks to overcome persistent bottlenecks in creating new tools that can radically improve health in the developing world.

15 Mar 2012

New study suggests another benefit to antimicrobial stewardship

Curbing unnecessary use of antibiotics is our best defense against the spread of drug-resistant infections. A new study suggests another benefit to antimicrobial stewardship: a potential cost savings of millions of dollars now wasted on therapies that don't help patients.

15 Mar 2012

New position paper outlines national approach to antimicrobial stewardship

As the supply of life-saving antibiotics becomes increasingly threatened, infectious diseases experts urge healthcare systems and policymakers to step up efforts to protect patients by preserving the effectiveness of available antibiotics through antimicrobial stewardship initiatives.

15 Mar 2012

UCSF's School of Pharmacy ranks first and School of Medicine ranks third in nationwide survey

UCSF's School of Pharmacy ranked first in its field this year, while its School of Medicine tied for third place nationwide, according to a new survey conducted by U.S. News & World Report.

14 Mar 2012

Antibody-based therapies successfully protect monkeys from deadly Ebola and Marburg viruses

Army scientists have demonstrated, for the first time, that antibody-based therapies can successfully protect monkeys from the deadly Ebola and Marburg viruses. In addition, the animals were fully protected even when treatment was administered two days post-infection, an accomplishment unmatched by any experimental therapy for these viruses to date.

14 Mar 2012

Misconception that syphilis has 'disappeared' presents major impediment to preventing infant deaths

In this Globe and Mail opinion piece, columnist Andre Picard examines the efforts of a new group, the Global Congenital Syphilis Partnership -- which includes the Bill & Melinda Gates Foundation, Save The Children, the CDC, the London School of Hygiene & Tropical Medicine, and the WHO -- to "make screening for syphilis a routine part of pregnancy care with the goal of eliminating congenital syphilis."

14 Mar 2012

Infectious Diseases News and Research

PaxVax announces FDA acceptance of IND for PXVX-0200 cholera vaccine

Pfizer supports First World Congress on Healthy and Active Ageing

Deletion of Hms1 protein inhibits Candida albicans infection

Collaborative research discovers genetic marker that identifies pigs with reduced susceptibility to PRRS

Warming climate may increase risk from Chagas disease

Serious climate change-related health problems will affect the world's population

Third International Symposium on Thymosins in Health and Disease to take place on GW campus

Food borne ailments from imported products on the rise: CDC report

Imported food leading to more foodborne disease outbreaks

Linking HCV infected people with care is key to reducing related mortality and morbidity

GenVec 2011 net loss decreases to $7.4 million

Scientists discover direct biomarker of Chikungunya fever

H. pylori bacteria associated with elevated levels of HbA1c

People with higher socio-economic status in developing countries more likely to be obese

UMDNJ to receive TB biomarkers grant from Gates Foundation

New study suggests another benefit to antimicrobial stewardship

New position paper outlines national approach to antimicrobial stewardship

UCSF's School of Pharmacy ranks first and School of Medicine ranks third in nationwide survey

Antibody-based therapies successfully protect monkeys from deadly Ebola and Marburg viruses

Misconception that syphilis has 'disappeared' presents major impediment to preventing infant deaths

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News